Blinatumomab is associated with significantly higher event-free survival among children with newly diagnosed high-risk B-cell acute lymphoblastic leukemia (ALL), according to a study published in the Sept. 17 issue of the ...
45 minutes ago
0
0
E. coli in uncooked meat can cause diarrhea and food poisoning. Scientists, however, have found a way to turn the bacterium into a delivery agent that takes drugs straight to a tumor and transforms it into a tiny cancer drug ...
New research from the Garvan Institute of Medical Research has revealed for the first time that two closely related bowel diseases, currently treated in the same way, are fundamentally different. The findings help explain ...
5 hours ago
0
2
Researchers from City of Hope have developed a new "plug-and-play" technology that adds engineered molecules to chimeric antigen receptor (CAR) T cells after treatment, allowing scientists to better control the cells and ...
8 hours ago
0
5
For patients receiving immune checkpoint inhibitors (ICIs), rheumatic immune-related adverse events (rh-irAEs) are usually moderate or severe, with more than one-third leading to permanent ICI discontinuation, according to ...
1 hour ago
0
0
Until now, diagnosing skin tumors has relied on detecting visible changes to the skin, and Line-Field Confocal Optical Coherence Tomography (LC-OCT) is a well-established method used for diagnosis. Now, researchers at Friedrich-Alexander-Universität ...
6 hours ago
0
3
Research from stem cell charity Anthony Nolan, published in Transplantation and Cellular Therapy, has revealed that 1 in 50 people studied has an "especially useful" gene variant that could make them a particularly desirable ...
7 hours ago
0
3
Gevick Safarians remembers the conversations. Patients dealing with cancer and other diseases with very poor prognoses, hoping not for years but for months—a little more time to settle their affairs, to figure out who would ...
20 hours ago
0
11
Tumors require a blood supply to grow and survive. The blood vessels that nourish tumors can have different characteristics across cancer types and could be connected to patient survival and outcomes. Researchers from Mass ...
Sep 21, 2026
0
10
The chemotherapy agent doxorubicin is used successfully to treat a range of cancers but can, as a side effect, damage the heart muscle. Researchers at the Heidelberg Faculty of Medicine at Heidelberg University have now identified ...
Sep 21, 2026
0
6
